Greer Jattan

Greer Jattan has a strong background in sales and management within the pharmaceutical and biotechnology industries. Greer is currently serving as the Senior Director of Clinical Sales and Market Access at Oxford BioDynamics Plc. Prior to this role, they held positions at AstraZeneca, NantHealth, NantOmics, OncoPlex Diagnostics, Archimedes Pharma, Biogen, Biogen Idec, and GI/Wyeth. Throughout their career, Greer has demonstrated expertise in clinical sales, market access, strategic planning, and client engagement. Greer has successfully led multi-functional teams, developed nationwide initiatives, and provided molecularly driven decision support to healthcare providers. Greer also has experience managing sales teams and overseeing multi-million-dollar sales portfolios.

Greer Jattan attended Seton Hall University School of Law in 2008, where they completed the Health Care Compliance Certification Program. It is not specified how long this program lasted. Prior to that, Jattan pursued a Bachelor of Arts (BA) degree at Queens College, majoring in Biology/Anthropology. The duration of their studies at Queens College is not mentioned.